Dec 11, 2023 / 08:00PM GMT
Presentations at ASH
Dec 11, 2023 / 08:00PM GMT
=====================
Corporate Participants
=====================
* Pablo J. Cagnoni
Incyte Corporation - President and Head of Research & Development
* Patrick Mayes
Incyte Corporation - VP of Biotherapeutic Research
* Peter Langmuir
=====================
Conference Call Participants
=====================
* Conor Thomas MacKay
BMO Capital Markets Equity Research - Research Associate
* Derek Christian Archila
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
* Eva Xia Privitera
TD Cowen, Research Division - Associate
* Jay Olson
Oppenheimer & Co. Inc., Research Division - Executive Director & Senior Analyst
* Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst
* Leonid Timashev
RBC Capital Markets, Research Division - Biotechnology Analyst
* Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst &
Incyte Corp
(STU:ICY)
€
100.3
-0.15 (-0.15%)
Market Cap: 20.15 Bil
Enterprise Value: 16.66 Bil
PE Ratio: 16.23
PB Ratio: 4.09
GF Score: 87/100 Incyte Corp to Discuss the Key Data Presentations at ASH Transcript
Dec 11, 2023 / 08:00PM GMT
Release Date Price:
€52.58
(+3.63%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot